Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping
Clinical trial NCT03548766 · UNKNOWN
Trial details
- NCT number
- NCT03548766
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-20
- Primary completion
- 2021-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.